Dan Gorenstein is the senior reporter for Marketplace’s Health Desk, covering the business of healthcare.

Prior to Marketplace, Dan spent more than 11 years at New Hampshire Public Radio. He got his start in journalism at the Chicago Reporter; an investigative journal that examines race and class disparities in the Chicago area. He’s won numerous national and local awards, including the Society of Professional Journalist Sigma Delta Chi investigative reporting award.

You can follow him on Twitter at @dmgorenstein.

READ MORE

Features by Dan Gorenstein

In health care reform, art keeps patients in the picture

Local artist Regina Holliday has recruited a walking gallery of story tellers to make sure patients get as much attention as profits
Posted In: Obamacare, hospitals, doctors, art

Student loan interest D-Day: What's it mean?

Interest rates are supposed to go up July 1. How big is the hike and what does it really mean numbers-wise?
Posted In: student loan forgiveness, interest rates, student loan, higher education

1-800-Obamacare

The Obama administration launches its new HealthCare.gov website to get people signed up.
Posted In: health care, Obamacare, NBA

The FAA answers: Why can't I use my iPad at takeoff?

The productivity loss of takeoff and landing.
Posted In: Airlines, Tech, tablets

When insurance is too expensive no matter what

Federal subsidies will make it easier for millions of Americans to buy health coverage, but millions still won't be able to afford it.
Posted In: health care, Affordable Care Act, medicaid, health insurance

Doctors look to change the economics of obesity

The American Medical Association votes to classify obesity as a disease in a move that will broaden coverage for related treatments.
Posted In: obesity

Will coordinating health care cut your medical bill?

Accountable care organizations are supposed to be one of the money-saving saviors of health care reform, but some fear they could drive prices up.
Posted In: health care, health insurance, health care reform

In NSA surveillance, what choice do companies have?

New revelations show the federal government’s spying program isn’t contained to just telecommunications giant Verizon.
Posted In: nsa, FBI, surveillance, Obama

FDA to consider lifting safety warnings on Avandia, but is it too little, too late?

The FDA is expected to take another look at controversial diabetes drug Avandia after researchers at Duke have concluded the drug doesn't increase the risk of cardiovascular death as previously reported.
Posted In: diabetes, GlaxoSmithKline, FDA

A health datapalooza: Washington and private health care's quest to mine health data

For two days, nearly 2,000 data geeks, entrepreneurs, federal bureaucrats and medical folks will descend on Washington, D.C., hoping to help solve the nation’s health care crisis through algorithms and spreadsheets.
Posted In: health care, big data, data mining

Pages

 
 
With Generous Support From...